This novel mechanism not only uncovers a molecular mechanism by which Wnt5a signalling is re‐activated in cardiac fibroblasts during ischaemia in vivo, but also provides a novel target for exploring new drugs to improve the prognosis of ischaemic heart disease. The gene discussed is WNT5A; the disease is heart disorder.